UNICHEM LABORATORIES
Back to Cashflow Statement
|
UNICHEM LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.86 Cr | ₹184 Cr | ₹-106 Cr | ₹-81 Cr | ₹191 Cr |
What is the latest Cash Flow from Financing Activities ratio of UNICHEM LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹1.86 Cr |
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹-106 Cr |
| Mar2023 | ₹-81 Cr |
| Mar2022 | ₹191 Cr |
How is Cash Flow from Financing Activities of UNICHEM LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.86 Cr | -98.99 | |
| Mar2025 | ₹184 Cr | Positive | |
| Mar2024 | ₹-106 Cr | Negative | |
| Mar2023 | ₹-81 Cr | Negative | |
| Mar2022 | ₹191 Cr | - | |
Compare Cash Flow from Financing Activities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,577.4 Cr | 0.8% | -4.1% | 6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 0.8% |
-4.1% |
6.9% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses